Impact of Substance Use Disorder on ADHD and Its Treatment

Cited by (190)

Items 101–190 of 190

1. Update on consultation–liaison psychiatry (psychosomatic medicine)
   Thomas N. Wise · 2008 · Current Opinion in Psychiatry
2. The Patient’s Perspective on the Link Between ADHD and Substance Use
   Christina Nehlin, Fred Nyberg, Caisa Öster · 2014 · Journal of Attention Disorders
3. Attention Deficit Hyperactivity Disorder Is Associated With a More Severe Pattern of Cocaine Consumption in Cocaine Users From French West Indies
   Héloïse Delavenne, Nicolas Ballon, Aimé Charles‐Nicolas, Frederico Duarte Garcia, Florence Thibaut, Jérôme Lacoste · 2011 · Journal of Addiction Medicine
4. Seasonality and the changing adult/child prescription ratios in ADHD therapy.
   Elisa F Cascade, Amir H Kalali, Richard H. Weisler, Susan Lenderts · 2008 · Europe PMC (PubMed Central)
5. Differences in Adherence to Antihypertensive Medication Regimens According to Psychiatric Diagnosis: Results of a Korean Population-Based Study
   Ha Kyoung Kim, Jong Hyock Park, Jae‐Hyun Park, Jong Heun Kim · 2009 · Psychosomatic Medicine
6. Ethanol Interactions With Dexmethylphenidate and dl-Methylphenidate Spheroidal Oral Drug Absorption Systems in Healthy Volunteers
   Hao‐Jie Zhu, Kennerly S. Patrick, Arthur B. Straughn, Owen T. Reeves, Hilary Bernstein, Jian Shi, Heather J. Johnson, Joshua M. Knight, Aaron T. Smith, Robert J Malcolm et al. · 2017 · Journal of Clinical Psychopharmacology
7. Prevalence and factors associated with major depressive disorder among adolescents attending a primary care facility in Kampala, Uganda
   Leticia Kyohangirwe, Elialilia Sarikiaeli Okello, Justine Diana Namuli, Grace Ndeezi, Eugene Kinyanda · 2019 · Tropical Doctor
8. Screening, Diagnosis, and Treatment of Dyslipidemia Among Persons With Persistent Mental Illness: A Literature Review
   Erik R. Vanderlip, Jess G. Fiedorowicz, William Geoffrey Haynes · 2012 · Psychiatric Services
9. Technological Advances in the Treatment of Trauma
   Lisa A. Paul, Christina M. Hassija, Joshua Dean Clapp · 2012 · Behavior Modification
10. Phosphodiesterase 10A inhibitors as a novel therapeutic approach for schizophrenia
    Judith A. Siuciak, Christine A. Strick · 2007 · Expert Opinion on Drug Discovery
11. Probabilities of ADD/ADHD and Related Substance Use Among Canadian Adults
    Ross D. Connolly, David Speed, Jacqueline Hesson · 2016 · Journal of Attention Disorders
12. Likelihood of Attending Treatment for Anxiety Among Veteran Primary Care Patients: Patient Preferences for Treatment Attributes
    Robyn L. Shepardson, Jennifer Schum Funderburk · 2016 · Journal of Clinical Psychology in Medical Settings
13. A new genetic locus for antipsychotic-induced weight gain: A genome-wide study of first-episode psychosis patients using amisulpride (from the OPTiMiSE cohort)
    Sophie E. ter Hark, Stéphane Jamain, Dick Schijven, Bochao Danae Lin, Mark K. Bakker, Anne Boland, Jean‐François Deleuze, Réjane Troudet, Anil K. Malhotra, Sinan Gülöksüz et al. · 2020 · Journal of Psychopharmacology
14. Role of Ethnicity in Antipsychotic-Induced Weight Gain and Tardive Dyskinesia: Genes or Environment?
    Lai Fong Chan, Clement C.H. Zai, Marcellino Monda, Steven G. Potkin, James L. Kennedy, Gary J. Remington, Jeffrey Alan Lieberman, Herbert Y. Meltzer, Vincenzo De Luca · 2013 · Pharmacogenomics
15. Marijuana Legalization in Colorado: Increasing Potency, Changing Risk Perceptions, and Emerging Public Health Concerns for Youth
    Jesse D. Hinckley, Christian Jean Hopfer · 2021 · Adolescent Psychiatry
16. Prevalence of smoking, alcohol and substance use among adolescents with attention-deficit/hyperactivity disorder in Denmark compared with the general population
    Anders G. Madsen, Søren Dalsgaard · 2013 · Nordic Journal of Psychiatry
17. Association between olanzapine concentration and metabolic dysfunction in drug-naive and chronic patients: similarities and differences
    Dongyu Kang, Jinjun Lu, Wenqing Liu, Ping Shao, Renrong Wu · 2022 · Schizophrenia
18. Aripiprazole in the Treatment of Delusional Parasitosis With Ocular and Dermatologic Presentations
    Wei‐Lieh Huang, Li‐Ren Chang · 2013 · Journal of Clinical Psychopharmacology
19. The Appropriateness of Routine Medication Treatment for Schizophrenia
    Alexander S. Young, Noosha Niv, Amy N. Cohen, C. Kessler, Kirk P. McNagny · 2008 · Schizophrenia Bulletin
20. An Open Trial of Sustained Release Bupropion for Attention-Deficit/Hyperactivity Disorder in Adults with ADHD plus Substance Use Disorders.
    Timothy E. Wilens, Jefferson B. Prince, James G. Waxmonsky, Robert Doyle, Thomas Spencer, MaryKate Martelon, M F Evans · 2010 · PubMed
21. Psychiatric Comorbidity and Addiction Severity Differences in Patients With ADHD Seeking Treatment for Cannabis or Cocaine Use Disorders
    Nieves Martínez‐Luna, Constanza Daigre, Raúl Felipe Palma-Álvarez, Marta Perea-Ortueta, Lara Grau‐López, Carlos Roncero, Eudald Castell Panisello, Josep Antoni Ramos‐Quiroga · 2019 · Journal of Attention Disorders
22. Adult attention-deficit/hyperactivity disorder, risky substance use and substance use disorders: a follow-up study among young men
    Natalia Estévez-Lamorte, Simon Foster, Dominique Eich‐Höchli, Franz Moggi, Gerhard E. Gmel, Meichun Mohler‐Kuo · 2018 · European Archives of Psychiatry and Clinical Neuroscience
23. Regulation of pituitary adenylyl cyclase-activating polypeptide (PACAP, ADCYAP1: adenylyl cyclase-activating polypeptide 1) in the treatment of schizophrenia
    Shinsuke Matsuzaki, Masaya Tohyama · 2008 · Expert Opinion on Therapeutic Targets
24. Metabolic screening in primary care for patients with schizophrenia or schizoaffective disorder and taking antipsychotic medication
    Rāwiri Keenan, Lynne M. Chepulis, Joanna Ly, Sally Carter, Chunhuan Lao, Muhammad Asim, Abhijit Bhat, Shivam Deo, Kee Ping Lim, Ruzaimah Mohammed et al. · 2020 · Journal of Primary Health Care
25. Adult Outcomes of Childhood Dysregulation
    Robert R. Althoff, Frank C. Verhulst, David C. Rettew, James J. Hudziak, Jan van der Ende · 2010 · Journal of the American Academy of Child & Adolescent Psychiatry
26. Does consanguinity increase the risk of mental ilnesses? A population-based study
    Abdülbari Bener, Mohammed T. Abou‐Saleh, Ramzi M. Mohammad, Elnour E. Dafeeah, Antonio Ventriglio, Dinesh Bhugra · 2016 · International Journal of Culture and Mental Health
27. Association between the GIPR gene and the insulin level after glucose loading in schizophrenia patients treated with olanzapine
    Shin Ono, Yutaro Suzuki, Naoki Fukui, Takuro Sugai, Junzo Watanabe, Nobuto Tsuneyama, Toshiyuki Someya · 2011 · The Pharmacogenomics Journal
28. Addressing Dual Diagnosis Patients Suffering from Attention-Deficit Hyperactivity Disorders and Comorbid Substance Use Disorders: A Review of Treatment Considerations
    J. Martínez-Raga, Carlos Knecht, Raquel de Alvaro, N. Szerman, P. Ruíz · 2013 · Addictive Disorders & Their Treatment
29. Neuronal correlates of appetite regulation in patients with schizophrenia: Is there a basis for future appetite dysfunction?
    Ovidiu Lungu, Karyne Anselmo, Geneviève Létourneau, Adrianna Mendrek, Benjamin Stip, Olivier Lipp, Pierre Lalonde, Lahcen Aït Bentaleb, Émmanuel Stip · 2012 · European Psychiatry
30. Clinical Implications of the CATIE Schizophrenia Trials: Day-to-Day Management Lessons for Australasian Psychiatrists
    Peter A. Bick, Natalie P. Knoesen, David Jonathan Castle · 2007 · Australasian Psychiatry
31. Longitudinal Smoking Patterns: Do They Predict Symptoms of ADHD in Adults?
    Judith S. Brook, Elinor B. Balka, Chenshu Zhang, David W. Brook · 2015 · Journal of Attention Disorders
32. Financial and Ethical Considerations for Professionals in Psychology
    Hayley Treloar Padovano · 2010 · Ethics & Behavior
33. Guideline for Screening, Diagnosis and Treatment of ADHD in Adults with Substance Use Disorders
    F. Matthys, S. Stes, W. van den Brink, P. Joostens, D. Möbius, S. Tremmery, B. Sabbe · 2014 · International Journal of Mental Health and Addiction
34. Morbidity and mortality of women and men with intellectual and developmental disabilities newly initiating antipsychotic drugs
    Simone Natalie Vigod, Yona Lunsky, Virginie Cobigo, Andrew S. Wilton, Sarah Somerton, Dallas Peter Seitz · 2016 · BJPsych Open
35. TDAH et comorbidités en pédopsychiatrie. Pathologies psychiatriques, affections médicales, troubles de l’apprentissage et de la coordination
    Laura Masi, Martin Gignac · 2016 · Annales Médico-psychologiques revue psychiatrique
36. Cardiovascular risk in patients admitted for psychosis compared with findings from a population-based study
    Erik Johnsen, Rolf Gjestad, Rune A. Kroken, Liv Mellesdal, Else‐Marie Løberg, Hugo Arild Jørgensen · 2010 · Nordic Journal of Psychiatry
37. Alcohol and drug dependence in adults with attention-deficit/hyperactivity disorder: Data from Germany
    Martin D. Ohlmeier, Eva Goseberg, Mandy Roy, Wolfgang Dillo, Andreas Kordon, Vanessa Prox-Vagedes · 2011 · The European Journal of Psychiatry
38. Adolescent Cannabis Use, Comorbid Attention-Deficit/Hyperactivity Disorder, and Other Internalizing and Externalizing Disorders
    Karla Molinero, Jesse D. Hinckley · 2022 · Child and Adolescent Psychiatric Clinics of North America
39. TARC: Turkish aripiprazole consensus report- Aripiprazole use and switching from other antipsychotics to aripiprazole- consensus recommendations by a Turkish multidisciplinary panel
    Baybars Veznedaroğlu, Nesrin Dılbaz, Özcan Uzun, Erdal Işık · 2018 · Therapeutic Advances in Psychopharmacology
40. Mood and Anxiety Disorders and the Use of Services and Psychotropic Medication in an Immigrant Population: Findings from the Israel National Health Survey
    Alexander Michael Ponizovsky, Alexander Grinshpoon · 2009 · The Canadian Journal of Psychiatry
41. Development of Novel Tools for Dissection of Central Versus Peripheral Dopamine D2-Like Receptor Signaling in Dysglycemia
    Alessandro Bonifazi, Michael P. Ellenberger, Zachary J. Farino, Despoina Aslanoglou, Rana Rais, Sandra Pereira, Jose Oscar Mantilla-Rivas, Comfort A. Boateng, Amy J. Eshleman, Aaron J. Janowsky et al. · 2024 · Diabetes
42. Iloperidone: a new option for the treatment of schizophrenia
    Andrew J. Cutler · 2009 · Expert Review of Neurotherapeutics
43. [An interaction between a polymorphism of the serotonin transporter (5HTT) gene and the clinical picture of adolescents with combined type ofADHD (hyperkinetic disorder) and youth drinking].
    Izabela Gorzkowska, Grzegorz Gorzkowski, Agnieszka Samochowiec, Aleksandra Suchanecka, Jerzy Samochowiec · 2014 · PubMed
44. Metabolic Syndrome Prevalence and Reduction in Inmates Prescribed Antipsychotic Medications
    Rusty Reeves, Anthony C. Tamburello, Lisa DeBilio · 2017 · Journal of Correctional Health Care
45. Special Section on Implications of CATIE: Implications of CATIE for Mental Health Services Researchers
    Nancy H. Covell, Molly T. Finnerty, Susan M. Essock · 2008 · Psychiatric Services
46. Consensus International sur le dépistage, le diagnostic et le traitement des patients avec troubles de l’usage de substances en cas de comorbidité avec un trouble du déficit de l’attention avec ou sans hyperactivité
    M. V. van Kernebeek, F. Vorspan, C. Crunelle, W. van den Brink, Geert Dom, F. Moggi, M. Konstenius, J. Franck, F. Levin, G. van de Glind et al. · 2022 · Annales de Toxicologie Analytique
47. Treatment of Bipolar Disorders and Metabolic Syndrome: Implications for Primary Care
    Paul F. Bell, James P. McKenna, Brandon M. Roscoe · 2009 · Postgraduate Medicine
48. The impact of attention-deficit hyperactivity disorder across the lifespan on substance use disorders
    Soha Ibrahim, O. Abou El Magd, AhmedAbdel Kerim, H. Salama · 2015 · Egyptian Journal of Psychiatry
49. The Prevalence and Determinants of Desire for and Use of Psychological Support in Patients With Low Vision
    Bonnie Adele Sturrock, Jing Xie, Edith Eva Holloway, Ecosse Luc Lamoureux, Jill Elizabeth Keeffe, Eva Fenwick, Gwyneth Rees · 2014 · Asia-Pacific Journal of Ophthalmology
50. Success for the ADHD College Student
    Stephanie Moulton Sarkis · 2008 · The ADHD Report
51. Aripiprazole in young people with early psychosis: a systematic review and meta-analysis of weight gain
    Arti Parmar, Donald Hulme, Daniel Hacking, Gordon Shymko, Milan Dragović, Terina Grace, Flavie Waters · 2022 · Australasian Psychiatry
52. Overcoming barriers in the pharmacological treatment of anxiety disorders
    David S. Baldwin, Rizwan Rafiq, Bilal Talat · 2013 · Neuropsychiatry
53. Adult Attention Deficit Hyperactivity Disorder (ADHD) in ASD
    Luana Salerno, J. J. Sandra Kooij · 2019 · Springer eBooks
54. The SASOP/PsychMg child and adolescent attention-deficit/hyperactivity disorder guidelines
    Brendan Belsham, Linda Kelly, Renata Schoeman · 2025 · South African Journal of Psychiatry
55. Psychoactive substance use in patients diagnosed with attention-deficit/hyperactivity disorder: an exploratory study
    Gniewko Więckiewicz, Iga Stokłosa, Maciej Stokłosa, Włodzimierz Więckiewicz, Piotr Wacław Gorczyca, Tomasz Maciej Gondek · 2023 · Frontiers in Psychiatry
56. Diagnostic Assessment
    J. J. Sandra Kooij · 2012 · Springer eBooks
57. Sensitive UHPLC-MS/SRM method for quantifying olanzapine metabolites and degradation products from sera
    Kannan Rangiah · 2014 · Analytical Methods
58. Evaluation of adult attention deficit hyperactivity disorder in smokers and Maras powder users
    H. Keten, H. Onay, Ozgur Ersoy, Oğuz Işık, Salih Gençoğlan, Huseyin Ucer, M. Çelik · 2015 · Nordic Journal of Psychiatry
59. Attention-deficit hyperactivity disorder (ADHD) in adults attending addiction treatment in Ireland: preliminary international ADHD in substance-use disorders prevalence study (IASP) results
    Marie Claire Van Hout, Michelle Foley · 2013 · Irish Journal of Psychological Medicine
60. Waist circumference does not predict insulin resistance in African American schizophrenia patients
    Bernice B. Rumala, Xiaoduo Fan, Bikash Sharma, Dana Diem Nguyen, Christina P. C. Borba, Leah B. Namey Briggs, Sharon Forstbauer, Kate Miley, David C. Henderson · 2008 · International Journal of Culture and Mental Health
61. Genetic and Environmental Determinants of Addiction Risk Related to Impulsivity and Its Neurobiological Substrates
    Michelle M. Jacobs, Didier Jutras‐Aswad, Jennifer A. DiNieri, Hilarie C. Tomasiewicz, Yasmin L. Hurd · 2011 · Springer eBooks
62. Structural imaging of substance abuse
    Sandra Chanraud, Anne‐Lise Pitel, Edith V. Sullivan · 2010 · Cambridge University Press eBooks
63. The value of an inter-agency pathway for Attention Deficit Hyperactivity Disorder (ADHD)
    Lucy Russell, Fiona Forbes, Kirsty Forsyth, Donald Maciver, Amanda Mulvanny, Jacqueline Whitehead · 2011 · International Journal of Therapy and Rehabilitation
64. Manejo clínico de pacientes con diagnóstico dual. Evaluación diagnóstica de los pacientes farmacodependientes que sufren de comorbilidad psiquiátrica
    Juan Francisco Gálvez Flórez, David Andrés Rincón Salazar · 2008 · Redalyc (Universidad Autónoma del Estado de México)
65. Obesity: Genetics, Pathogenesis, Therapy
    Hannah Mathew, Stavroula Α. Paschou, Kalliopi M. Aramapatzi, William C. Hsu, Christos Socrates Mantzoros · 2017 · Springer eBooks
66. Concept, Prevalence and Clinical Profile of Adult ADHD with a Special Focus on India: A Systematic Review
    Sumit Kumar Mishra, Lokesh Singh Shekhawat, Naorem Kiranmala Devi · 2025 · Journal of Indian Association for Child and Adolescent Mental Health
67. Schizophrenia: 1979-2009
    Mary V. Seeman · 2009 · Clinical Schizophrenia & Related Psychoses
68. Laboratory aspects of specific psychiatric disorders
    2008 · CRC Press eBooks
69. 注意欠如多動性障害（ADHD）の疫学と病態：遺伝要因と環境要因の関係性の視点から
    光一 吉益 · 2020 · 日本健康医学会雑誌
70. Adolescent Cannabis Use, Comorbid Attention-Deficit/Hyperactivity Disorder, and Other Internalizing and Externalizing Disorders
    Karla Molinero, Jesse D. Hinckley · 2023 · Psychiatric Clinics of North America
71. Adult ADHD in Substance-Related and Addictive Disorders
    Stefano Pallanti, Luana Salerno · 2020 · Springer eBooks
72. Diagnostics
    J. J. Sandra Kooij · 2021 · Springer eBooks
73. Outcomes in the Treatment of Major Depressive Disorder
    Michael E. Thase, Aaron M. Koenig · 2009 · Medical psychiatry
74. Obesity: Genetics, Pathogenesis, Therapy
    Stavroula Α. Paschou, Hannah Mathew, Christos Socrates Mantzoros · 2015 · Springer eBooks
75. ADHD medication use and long-term consequences
    Els F. van den Ban · 2014 · Utrecht University Repository (Utrecht University)
76. Obesity – Genetics, Pathogenesis, Therapy
    William C. Hsu, Kalliopi M. Arampatzi, Christos Socrates Mantzoros · 2009 · Springer eBooks
77. Incentives to Reduce Metabolic Side Effects of Antipsychotics
    Edward L. Knight, Alexander S. Young · 2011 · Psychiatric Services
78. Substance use disorders and attention-deficit/hyperactivity disorder: A review of recent developments
    Oscar Gary Bukstein · 2009 · Current Attention Disorders Reports
79. Managing the physical health needs of service users
    Ruth Elston, Paul Linsley · 2014 · British Journal of Mental Health Nursing
80. Prevalence, Symptom Patterns and Comorbidity of Anxiety and Depressive Disorders in Primary Care in Qatar
    Abdülbari Bener, Suhaila Ghuloum, Mohammed T. Abou‐Saleh · 2010 · Journal of Men s Health
81. Outcomes in the Treatment of Major Depressive Disorder
    Michael E. Thase, Aaron M. Koenig · 2009
82. La doppia diagnosi ADHD e SUD
    Gianmaria Zita, Giovanni Migliarese · 2020 · MISSION
83. Trouble déficit de l'attention-hyperactivité (TDAH) : de l'adolescence à l'âge adulte. Particularités cliniques et thérapeutiques
    J. Bouchez, Hassan Rahioui, François Bayle, Hervé M. Caci · 2021 · EMC - Psychiatrie
84. ADHD Comorbidities
    Joseph R. Sadek · 2013 · Springer eBooks
85. References
    2011 · Wiley eBooks
86. Laboratory aspects of specific psychiatric disorders
    Russell Foster · 2008 · CRC Press eBooks
87. Obesity: Genetics, Pathogenesis, and Therapy
    Hannah Mathew, Stavroula Α. Paschou, Kalliopi M. Aramapatzi, William C. Hsu, Christos Socrates Mantzoros · 2017 · Springer eBooks
88. BindingDB Entry 50003321: Synthesis and Biological Evaluation of Fused Tricyclic Heterocycle Piperazine (Piperidine) Derivatives As Potential Multireceptor Atypical Antipsychotics.
    BindingDB · 2020 · UC San Diego
89. BindingDB Entry 50027102: Structure-activity relationships for a novel series of dopamine D2-like receptor ligands based on N-substituted 3-aryl-8-azabicyclo[3.2.1]octan-3-ol.
    BindingDB · 2010 · UC San Diego
90. Patterns of Drug Use in Carriers of Attention Deficit and Hyperactivity Disorder (ADHD)
    Alfredo Löhr, Marco Antônio Bessa · 2015 · Springer eBooks